![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 49, 35219-35226, December 3, 1999
§,
,
,
§,
,
From the We have used adenovirus-mediated gene transfer in
mice to investigate low density lipoprotein receptor (LDLR) and
LDLR-related protein (LRP)-independent mechanisms that control the
metabolism of chylomicron and very low density lipoprotein (VLDL)
remnants in vivo. Overexpression of receptor-associated
protein (RAP) in mice that lack both LRP and LDLR
(MX1cre+LRPflox/floxLDLR
Department of Biopharmaceutics,
Leiden/Amsterdam Center for Drug Research, Leiden 2300 RA, The
Netherlands, § TNO Prevention and Health, Gaubius
Laboratory, Leiden 2300 RA, The Netherlands, the ¶ Department of
Molecular Genetics, University of Texas Southwestern Medical Center,
Dallas, Texas 75235, the
Division of Nutritional Sciences,
Cornell University, Ithaca, New York 14853, and ** Departments of
Cardiology and Internal Medicine, Leiden University Medical Center,
Leiden 2300 RA, The Netherlands
/
) in
their livers elicited a marked hypertriglyceridemia in addition to the
pre-existing hypercholesterolemia in these animals, resulting in a
shift in the distribution of plasma lipids from LDL-sized lipoproteins
to large VLDL-sized particles. This dramatic increase in plasma lipids
was not due to a RAP-mediated inhibition of a unknown hepatic high
affinity binding site involved in lipoprotein metabolism, because no
RAP binding could be detected in livers of
MX1cre+LRPflox/floxLDLR
/
mice
using both membrane binding studies and ligand blotting experiments.
Remarkably, RAP overexpression also resulted in a 7-fold increase (from
13.6 to 95.6 ng/ml) of circulating, but largely inactive, lipoprotein
lipase (LPL). In contrast, plasma hepatic lipase levels and activity
were unaffected. In vitro studies showed that RAP binds to
LPL with high affinity (Kd = 5 nM) but
does not affect its catalytic activity, in vitro or in vivo. Our findings suggest that an extrahepatic
RAP-sensitive process that is independent of the LDLR or LRP is
involved in metabolism of triglyceride-rich lipoproteins. There, RAP
may affect the functional maturation of LPL, thus causing the
accumulation of triglyceride-rich lipoproteins in the circulation.
This article has been cited by other articles:
![]() |
L. Hu, C. C. van der Hoogt, S. M. S. Espirito Santo, R. Out, K. E. Kypreos, B. J. M. van Vlijmen, T. J. C. Van Berkel, J. A. Romijn, L. M. Havekes, K. W. van Dijk, et al. The hepatic uptake of VLDL in lrp-ldlr-/-vldlr-/- mice is regulated by LPL activity and involves proteoglycans and SR-BI J. Lipid Res., July 1, 2008; 49(7): 1553 - 1561. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lichtenstein, J. F.P. Berbee, S. J. van Dijk, K. W. van Dijk, A. Bensadoun, I. P. Kema, P. J. Voshol, M. Muller, P. C.N. Rensen, and S. Kersten Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2420 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hu, L.S.M. Boesten, P. May, J. Herz, N. Bovenschen, M.V. Huisman, J.F.P. Berbee, L.M. Havekes, B.J.M. van Vlijmen, and J.T. Tamsma Macrophage Low-Density Lipoprotein Receptor-Related Protein Deficiency Enhances Atherosclerosis in ApoE/LDLR Double Knockout Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2710 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Page, A. Judson, K. Melford, and A. Bensadoun Interaction of Lipoprotein Lipase and Receptor-associated Protein J. Biol. Chem., May 19, 2006; 281(20): 13931 - 13938. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Millar, D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339 J. Lipid Res., September 1, 2005; 46(9): 2023 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. S. E. Santo, P. C. N. Rensen, J. R. Goudriaan, A. Bensadoun, N. Bovenschen, P. J. Voshol, L. M. Havekes, and B. J. M. van Vlijmen Triglyceride-rich lipoprotein metabolism in unique VLDL receptor, LDL receptor, and LRP triple-deficient mice J. Lipid Res., June 1, 2005; 46(6): 1097 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. May, A. Rohlmann, H. H. Bock, K. Zurhove, J. D. Marth, E. D. Schomburg, J. L. Noebels, U. Beffert, J. D. Sweatt, E. J. Weeber, et al. Neuronal LRP1 Functionally Associates with Postsynaptic Proteins and Is Required for Normal Motor Function in Mice Mol. Cell. Biol., October 15, 2004; 24(20): 8872 - 8883. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Verseyden, S. Meijssen, and M. C. Cabezas Effects of Atorvastatin on Fasting Plasma and Marginated Apolipoproteins B48 and B100 in Large, Triglyceride-Rich Lipoproteins in Familial Combined Hyperlipidemia J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5021 - 5029. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Augustus, H. Yagyu, G. Haemmerle, A. Bensadoun, R. K. Vikramadithyan, S.-Y. Park, J. K. Kim, R. Zechner, and I. J. Goldberg Cardiac-specific Knock-out of Lipoprotein Lipase Alters Plasma Lipoprotein Triglyceride Metabolism and Cardiac Gene Expression J. Biol. Chem., June 11, 2004; 279(24): 25050 - 25057. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. S. Espirito Santo, N. M. M. Pires, L. S. M. Boesten, G. Gerritsen, N. Bovenschen, K. W. van Dijk, J. W. Jukema, H. M. G. Princen, A. Bensadoun, W.-P. Li, et al. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol Blood, May 15, 2004; 103(10): 3777 - 3782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Verges, A. Bensadoun, J. Herz, J. D. Belcher, and R. J. Havel Endocytosis of Hepatic Lipase and Lipoprotein Lipase into Rat Liver Hepatocytes in Vivo Is Mediated by the Low Density Lipoprotein Receptor-related Protein J. Biol. Chem., March 5, 2004; 279(10): 9030 - 9036. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bovenschen, J. Herz, J. M. Grimbergen, P. J. Lenting, L. M. Havekes, K. Mertens, and B. J. M. van Vlijmen Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency Blood, May 15, 2003; 101(10): 3933 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yagyu, E. P. Lutz, Y. Kako, S. Marks, Y. Hu, S. Y. Choi, A. Bensadoun, and I. J. Goldberg Very Low Density Lipoprotein (VLDL) Receptor-deficient Mice Have Reduced Lipoprotein Lipase Activity. POSSIBLE CAUSES OF HYPERTRIGLYCERIDEMIA AND REDUCED BODY MASS WITH VLDL RECEPTOR DEFICIENCY J. Biol. Chem., March 15, 2002; 277(12): 10037 - 10043. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Goudriaan, P. J. Tacken, V. E.H. Dahlmans, M. J.J. Gijbels, K. W. van Dijk, L. M. Havekes, and M. C. Jong Protection From Obesity in Mice Lacking the VLDL Receptor Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1488 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Tacken, B. Teusink, M. C. Jong, D. Harats, L. M. Havekes, K. W. van Dijk, and M. H. Hofker LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice J. Lipid Res., December 1, 2000; 41(12): 2055 - 2062. [Abstract] [Full Text] |
||||
![]() |
J. C. Obunike, E. P. Lutz, Z. Li, L. Paka, T. Katopodis, D. K. Strickland, K. F. Kozarsky, S. Pillarisetti, and I. J. Goldberg Transcytosis of Lipoprotein Lipase across Cultured Endothelial Cells Requires Both Heparan Sulfate Proteoglycans and the Very Low Density Lipoprotein Receptor J. Biol. Chem., March 16, 2001; 276(12): 8934 - 8941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sousa and M. J. Saraiva Internalization of Transthyretin. EVIDENCE OF A NOVEL YET UNIDENTIFIED RECEPTOR-ASSOCIATED PROTEIN (RAP)-SENSITIVE RECEPTOR J. Biol. Chem., April 20, 2001; 276(17): 14420 - 14425. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |